CA2318374C - Human suppressor trna oligonucleotides and methods of use for same - Google Patents

Human suppressor trna oligonucleotides and methods of use for same Download PDF

Info

Publication number
CA2318374C
CA2318374C CA2318374A CA2318374A CA2318374C CA 2318374 C CA2318374 C CA 2318374C CA 2318374 A CA2318374 A CA 2318374A CA 2318374 A CA2318374 A CA 2318374A CA 2318374 C CA2318374 C CA 2318374C
Authority
CA
Canada
Prior art keywords
trna
vector
oligonucleotide
region
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2318374A
Other languages
English (en)
French (fr)
Other versions
CA2318374A1 (en
Inventor
Rekha G. Panchal
Charles J. Link, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Gene Therapy Research Institute
Original Assignee
Human Gene Therapy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Gene Therapy Research Institute filed Critical Human Gene Therapy Research Institute
Publication of CA2318374A1 publication Critical patent/CA2318374A1/en
Application granted granted Critical
Publication of CA2318374C publication Critical patent/CA2318374C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04B—TRANSMISSION
    • H04B10/00—Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
    • H04B10/25—Arrangements specific to fibre transmission
    • H04B10/2589—Bidirectional transmission
    • H04B10/25891—Transmission components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Electromagnetism (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CA2318374A 1998-01-14 1999-01-13 Human suppressor trna oligonucleotides and methods of use for same Expired - Fee Related CA2318374C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7141698P 1998-01-14 1998-01-14
US60/071,416 1998-01-14
PCT/US1999/000717 WO1999036519A1 (en) 1998-01-14 1999-01-13 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME

Publications (2)

Publication Number Publication Date
CA2318374A1 CA2318374A1 (en) 1999-07-22
CA2318374C true CA2318374C (en) 2012-09-04

Family

ID=22101183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2318374A Expired - Fee Related CA2318374C (en) 1998-01-14 1999-01-13 Human suppressor trna oligonucleotides and methods of use for same

Country Status (8)

Country Link
US (2) US6309830B1 (cg-RX-API-DMAC7.html)
EP (1) EP1045902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002508959A (cg-RX-API-DMAC7.html)
AT (1) ATE299179T1 (cg-RX-API-DMAC7.html)
AU (1) AU2225199A (cg-RX-API-DMAC7.html)
CA (1) CA2318374C (cg-RX-API-DMAC7.html)
DE (1) DE69926052T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999036519A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法
KR20010079671A (ko) * 1998-08-20 2001-08-22 스티븐 에이. 서윈. 엠.디. 재조합 유전자 생성물을 생성시키는 동안 세포독성을조절하는 억제 tRNA의 용도
WO2003033521A1 (en) * 2001-10-16 2003-04-24 Massachusetts Institute Of Technology Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
US20050261210A1 (en) * 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
WO2005086768A2 (en) * 2004-03-11 2005-09-22 Albert Einstein College Of Medicine Of Yeshiva University Enhanced production of functional proteins from defective genes
WO2008064304A2 (en) * 2006-11-22 2008-05-29 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
ATE553764T1 (de) * 2007-09-14 2012-05-15 Trana Discovery Zusammensetzungen und verfahren zur identifizierung von inhibitoren einer retrovirusinfektion
CA2776044A1 (en) * 2008-09-29 2010-04-01 Trana Discovery, Inc. Screening methods for identifying specific staphylococcus aureus inhibitors
CN107177592B (zh) * 2016-03-10 2021-03-30 北京大学 抑制性tRNA通读提前终止密码子疾病中的截短蛋白
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
MX2020004587A (es) * 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022528696A (ja) * 2019-04-11 2022-06-15 アークタラス テラピュウティクス、インク アンチコドンループを延長した合成転移rna
LU101182B1 (en) * 2019-04-11 2020-10-12 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US11827880B2 (en) 2019-12-02 2023-11-28 Shape Therapeutics Inc. Therapeutic editing
BR112022020780A2 (pt) 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
WO2022125531A1 (en) * 2020-12-07 2022-06-16 President And Fellows Of Harvard College Methods for making and using genomically recoded cells
AU2023212951A1 (en) * 2022-01-25 2024-08-29 Hc Bioscience, Inc. Universal suppressor trnas and uses thereof
USD1118947S1 (en) * 2024-05-29 2026-03-17 Shock Doctor, Inc. Knee brace
USD1121161S1 (en) * 2024-05-29 2026-03-31 Shock Doctor, Inc. Knee brace

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687737A (en) 1982-11-12 1987-08-18 Massachusetts Institute Of Technology Mammalian suppressor genes
US4970155A (en) * 1983-03-07 1990-11-13 Abbott Laboratories HSV helper virus independent vector
US6111095A (en) * 1995-06-07 2000-08-29 Merck & Co., Inc. Capped synthetic RNA, analogs, and aptamers
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法

Also Published As

Publication number Publication date
CA2318374A1 (en) 1999-07-22
US7029665B2 (en) 2006-04-18
DE69926052T2 (de) 2006-04-27
EP1045902A1 (en) 2000-10-25
US20020156042A1 (en) 2002-10-24
JP2002508959A (ja) 2002-03-26
DE69926052D1 (de) 2005-08-11
WO1999036519A1 (en) 1999-07-22
EP1045902B1 (en) 2005-07-06
AU2225199A (en) 1999-08-02
ATE299179T1 (de) 2005-07-15
US6309830B1 (en) 2001-10-30
HK1033955A1 (en) 2001-10-05

Similar Documents

Publication Publication Date Title
EP1045902B1 (en) HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
EP0454781B1 (en) Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
US5861290A (en) Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
US5830727A (en) Herpes simplex virus amplicon mini-vector gene transfer system
AU2016373365B2 (en) Transposon system, kit comprising the same, and uses thereof
EP3822346A1 (en) Use of engineered packaging cell lines for producing recombinant virus particles
EP2406379A1 (en) Compositions and methods for the delivery of biologically active rnas
JP6608284B2 (ja) 癌の治療に使用されるrnaトランススプライシング分子(rtm)
Panchal et al. Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA
US20140170709A1 (en) Vector for gene therapy
EP3359676B1 (en) Transposon system, kit comprising the same, and uses thereof
JP2025148442A (ja) Rnaによる単純ヘルペス ウイルスi型およびその他の関連するヒトヘルペス ウイルスの根絶
HK1033955B (en) Human suppressor trna oligonucleotides and methods of use for same
Semple-Rowland et al. Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells
US20230220361A1 (en) Crispr-cas9 mediated disruption of alcam gene inhibits adhesion and trans-endothelial migration of myeloid cells
EP0796338B1 (fr) Lignees cellulaires d'encapsidation pour la transcomplementation de vecteurs retroviraux defectifs
EP1045920A1 (en) Nucleotide expression systems with reduced immunogenicity for use in gene therapy
US20230279398A1 (en) Treating human t-cell leukemia virus by gene editing
WO2026003067A1 (en) Transcription factors and reprogramming modulators for reprogramming cells to cdc1 cells, compositions and methods thereof
US20050266544A1 (en) Methods and compositions for increasing viral vector production in packaging cell lines
Georgiadis Viral vector-mediated RNA interference in the retina
Csonka Generation of prototype human satellite DNA-based artificial chromosomes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190114